The trial was prematurely halted because it appeared unlikely to demonstrate any health benefit in supplemented patients about one-third of participants completed the trial at the time of study termination (75)
In turn, induction of mucin gene expression, mucous production and airway hyperreactivity were dramatically decreased in GGT enu1 mutant mice
Please consult a doctor
For three decades, BPC-157 has been one of the most talked-about peptides in research and biohacking circles and yet, as of early 2026, not a single properly controlled human trial had been completed
What Would Change This View A negative RCT in living skin If a properly powered randomized trial of at-home microinfusion with GHK-Cu versus matched topical control failed to show histologic or photographic differences at 12 weeks, that result would shift the position of this article from "biologically plausible recommendation" to "interesting hypothesis pending data." A safety signal in long-term at-home users If the consumer at-home microinfusion category began producing case reports of infection, scarring, or persistent dermal damage at rates higher than baseline microneedling, the depth recommendation would tighten or the route would be deprecated
It offers the best balance of capacity, readability, and precision for the most common BPC 157 dosing protocols
